Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Myofibroblasts produce the fibrous scar in hepatic fibrosis. In the carbon tetrachloride (CCl(4)) model of liver fibrosis, quiescent hepatic stellate cells (HSC) are activated to become myofibroblasts. When the underlying etiological agent is removed, clinical and experimental fibrosis undergoes a remarkable regression with complete disappearance of these myofibroblasts. Although some myofibroblasts apoptose, it is unknown whether other myofibroblasts may revert to an inactive phenotype during regression of fibrosis. We elucidated the fate of HSCs/myofibroblasts during recovery from CCl(4)- and alcohol-induced liver fibrosis using Cre-LoxP-based genetic labeling of myofibroblasts. Here we demonstrate that half of the myofibroblasts escape apoptosis during regression of liver fibrosis, down-regulate fibrogenic genes, and acquire a phenotype similar to, but distinct from, quiescent HSCs in their ability to more rapidly reactivate into myofibroblasts in response to fibrogenic stimuli and strongly contribute to liver fibrosis. Inactivation of HSCs was associated with up-regulation of the anti-apoptotic genes Hspa1a/b, which participate in the survival of HSCs in culture and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, restored RSPO3 expression during HSC deactivation52,53 or by therapeutic interventions might help to regain hepatocyte functions.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [52]
In the citing paper
“Animal models reinforce the capacity of the injured liver to regress fibrosis and provide important platform for dissecting underlying mechanisms, although it should be noted that fibrosis in mice regresses incredibly rapidly, which may be in part attributed to the short duration of models (weeks to months in mice vs. years to decades in humans) and initiation of fibrosis at relatively young age (”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [262]
In the citing paper
“Fibroblast activation also involves increased activity of key glycolytic enzymes, such as hexokinase 2 and lactate dehydrogenase (LDH)47, which in turn increase cell proliferation47 and collagen synthesis48.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
In the citing paper
“During enhanced glycolysis, increased amounts of pyruvate are converted to acetyl-CoA in the mitochondrial matrix47 before entering the citric acid cycle. This yields intermediate metabolites, such as succinate, which promote fibrosis49.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citationBataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 8×
“Myofibroblasts are aSMA collagen type I cells that are absent from the normal uninjured liver, rapidly emerge infibrotic liver to produce thefibrous scar, and completely disappear with regression of liver fibrosis (1, 2).”
BackgroundInfluentialThe role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Cited by
Items 801–889 of 889
Development of Therapy for Liver Fibrosis: Molecular/cellular basis and overcoming challenges
Inagaki, Y., & Yanagawa, T. (2024) · Kanzo · doi:10.2957/kanzo.65.305
Research Progress on the Effects of Nicotinamide Riboside on Non-Alcoholic Fatty Liver Disease
卞, 春. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151151
Les fibulines, de nouveaux acteurs dans les maladies chroniques hépatiques
Thomas, C. (2024) · theses.fr (ABES) · doi:10.70675/5ecd5f64zca9ez4ce8zbf8dz62e4fa112860
The Role of HSP47 in Heart Failure and Other Fibrotic Diseases
段, 荣. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152455
Ooka, A., Yamaguchi, M., Suzuki, K., Saito, S., Kaneko, Y. K., Kimura, T., & Ishikawa, T. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167802
Copple, B. L., & Poole, L. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00240-0
Ducousso, M., Montani, M., Bosch, J., Berzigotti, A., & Mendoza, Y. P. (2025) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-6018
Follicular helper T cells and fibrotic diseases
Ma, Y., Zhou, Y., & Yu, M. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.105024
Gallegos, E. M., Couvillion, K. E., & Simon, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34258-5.00004-9
Liang, T.-R., Liu, C., & Peng, S.-Y. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013825
Modulation der Interaktion zwischen Integrinen und der extrazellulären Matrix in der Fibrose
Hamelmann, S. (2023) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00032789
Baker, S. F. (2023) · cIRcle (University of British Columbia) · doi:10.14288/1.0435202
Mechanistic Elucidation of the Function of Sirtuin 6 in the Regulation of Liver Fibrosis
Chowdhury, K. (2022) · IUScholarWorks (Indiana University) · doi:10.7912/c2/3065
Norona, L. M. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/yvx7-xr84
Suppression of hepatic fibrosis by efficient Col1a1 silencing using shRNA inducible mouse models
Molokanova, O. (2018) · Gutenberg Open Science · doi:10.25358/openscience-4470
Wan, G., Chen, Z., Lei, L., Geng, X., Zhang, Y., Yang, C., 曹文富, & Pan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26571151
Type 3 cytokine responses during Non-Alcoholic Fatty Liver Disease (NAFLD)
Abdelnabi, M. N. (2022) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/30753
Poveda, B. M., Guadix, J. A., & Medina, M. Á. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The role of connexins, pannexins and their channels in liver fibrosis
Yanguas, S. C. (2018) · VUBIR (Vrije Universiteit Brussel)
The Role of ERRα in dictating the hepatic metabolic response to dietary sugars, fructose and glucose
Guluzian, C. (2023) · eScholarship@McGill (McGill) · doi:10.82308/8588
Effect of senescence on human mesenchymal stromal cells’ anti-fibrotic function
Morales, I. E. A. (2024) · eScholarship@McGill (McGill) · doi:10.82308/33863
D'Urso, M. (2025) · TU/e Research Portal
Antiretroviral therapy and its role in the progression of acute and chronic liver injury
Martí-Rodrigo, A. (2019) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Fibrotik hücrelerin karaciğerde tanımlanması
Bozlar, M. (2022) · Bilkent University Institutional Repository (Bilkent University)
К ВОПРОСУ СТРОМАЛЬНЫХ ЭЛЕМЕНТОВ ПЕЧЕНИ В НОРМЕ И ПРИ ХОЛЕСТАЗЕ
Saidalievich, S. K. (2025) · Eurasian Journal of Medical and Natural Sciences · doi:10.70413/ejmns-v05-i10-s10796
Amengual Segura, J. (2024) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Hepatic stellate cells in liver fibrosis: From biology to pathology
Esselmani, H., Nadir, Y., Ennadi, R., Zouhairi, N., Hiba, O. E., Lkousse, M. A., Najimi, M., & Merzouki, M. (2025) · Open Veterinary Journal · doi:10.5455/ovj.2025.v15.i12.4
Reghelin, C. K. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Efeito da liraglutida sobre a fibrose hepática e células estreladas ativadas
de Mesquita, F. C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Di, Y., Jin, L., Zhang, X., Deng, P., Gao, F., & Jin, S. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05504-2
Role of hepatic stellate cells in liver fibrosis
Brenner-Wyss, L., Hofmann, I., Rieder, M.-A., & Lehmann-Frey, K. (2020) · International journal of hepatology sciences. · doi:10.33545/26649675.2020.v2.i2a.19
Li, J., Ni, Y., Huang, R., Zhang, Y., Wang, J., Hu, H., Li, M., & Liu, H. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112487
Dropmann, A., Dewidar, B., Gould, K., Baccetto, R. L., Meyer, C., Caccamo, T., Erdoesi, P., Ayvaz, Ş., Scheffschick, A., Damm, G., et al. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01554-7
Fibroblast memory Runx deep: epigenetic recall in pulmonary fibrosis
Kurche, J. S., & Redente, E. F. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag055
Rôle de l'autophagie macrophagique dans la maladie alcoolique du foie et la fibrose hépatique
Denaës, T. (2015) · theses.fr (ABES) · doi:10.70675/9da282e2zf867z4eb6zabe3z04aecf04b096
Thérapie cellulaire en endoscopie interventionnelle digestive
Rahmi, G. (2015) · theses.fr (ABES) · doi:10.70675/d6f34d07z8959z4328z984ezd46a49e5cd45
Monoacylglycerol Lipase, a new anti-inflammatory and anti-fibrogenic target in the liver
Chokr, D. (2018) · theses.fr (ABES) · doi:10.70675/6aac5cc4z3085z4939zb6c9ze439b795571f
Mise au point et développement de modèles hépatiques complexes par bio-impression 3D
Cuvellier, M. (2020) · theses.fr (ABES) · doi:10.70675/b6c577cdzcaffz460az8214z9681de8f3941
Guilcher, C. L. (2018) · theses.fr (ABES) · doi:10.70675/31755573zc52bz4020zb736za39dcd3e9230
Traitement de la fibrose pulmonaire idiopathique : Rôle de TRIM33 et de l’inhibition d’HSPB5
Boutanquoi, P. (2019) · theses.fr (ABES) · doi:10.70675/968e196dz45c0z4010za2dez22d692e030cc
Role of RIPK1 in the survival and death of hepatocytes : its involvement in murine hepatitis models
Farooq, M. (2019) · theses.fr (ABES) · doi:10.70675/5fe7950dz1147z4d64z9b9bz87bfd1d3ae35
Role of the protein ADAMTS12 in the progression of Chronic Liver Diseases
Azar, F. (2021) · theses.fr (ABES) · doi:10.70675/df5a3af0ze005z4d00z982fz020900d13f4e
L’empreinte métabolique du virus de l'hépatite D
Khomich, O. A. (2021) · theses.fr (ABES) · doi:10.70675/8bc031cdzb384z47fez9eb4z2c471cd55c93
Skelton, M. L., Leonard‐Duke, J., Astrab, L. R., Goedert, J. A., Hannan, R. T., PEIRCE, S. M., Sturek, J. M., & Caliari, S. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.722023
Jager, M. C. (2026) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2026.04.003
Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution
Lebeaupin, C., Donahue, K. L., Dower, K., Wynn, T. A., Hart, K. M., & Fabre, T. (2026) · JCI Insight · doi:10.1172/jci.insight.200155
Vujović, A. (2024) · National Repository of Dissertations in Serbia
Lian, Y.-J., Li, M., Wang, L., Gao, Y.-W., Zhu, D., & Lyu, W. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.121310
Liver Fibrosis and Purinergic Signaling: Autocrine–Paracrine Role of ATP in Liver Damage
Ramos-Rosillo, B. V., Martínez, E. M., Díaz‐Muñoz, M., & Vázquez‐Cuevas, F. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136030
Eskridge, W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.08.737277
Integrative analysis reveals gut microbiota-associated host regulatory networks in liver fibrosis
PENG, S., Nie, Y., Yuzhu, S., Ding, H., Cao, H., Wu, H., 祁建妮, & Zhu, Q. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1963640
Role of extracellular matrix in liver fibrosis regression and regeneration (Review)
Zhou, Y., Qiang, Z., Duan, Y., Huang, J., & Wang, H. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5942
Kandhi, R. (2016) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Nanopartikulär gekoppeltes Alendronat zur antifibrotischen Immunmodulation bei Leberfibrose
Choteschovsky, N. (2025) · Gutenberg Open Science · doi:10.25358/openscience-15937
An, P., Wu, L., & Wang, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119883
Koyama, K. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00073749
Lu, X., & Li, Z. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1912158
Baek, H., Lee, E.-C., Gonçalves, M., Ong, Y. T., Jeon, S., Jang, Y.-J., Kim, S., Seok, Y. J., Hong, S., Bhang, S. H., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.182254
Zhou, J., Liu, J., Wu, D., Ding, J., Li, B., & Yu, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1882205
Quantitative Characterization of Liver Fibrosis Using Near Infrared Spectroscopy
Oyewo, A. (2026) · UEF eRepo (University of Eastern Finland)
A role for SerpinB3 and Oncostatin M in the progression of NASH
Protopapa, F. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
Li, J.-P., Chen, X., Wang, Q., Du, Y.-Y., Guo, T.-T., Lin, J.-N., Fu, J.-Y., Xie, M.-L., Liu, J.-H., Gao, J.-L., et al. (2026) · World Journal of Stem Cells · doi:10.4252/wjsc.125689
Cossette, F.-X. (2026) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/36363
A Compact Regulatory Logic Governs Fibroblast Cell State Plasticity in FibrosisPreprint
Zhu, A. M., Li, Y., Zhang, H., Rathinasabapathi, B., Cimarosti, B., Nadadur, R. D., Xu, V., Huang, Y., An, Y., Auclair, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.09.757677
Qiao, R., Zhang, J., Gao, Y., & Li, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s623639
Bansal, M. B., & Friedman, S. L. (2026) · Wiley eBooks · doi:10.1002/9781394360031.ch8
Hepatocyte protection and stellate cell control by Salvia miltiorrhiza in liver fibrosis
Liu, Y., Li, W., Wu, W., Xu, Z., & Wu, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.2006283
Lu, W., Xu, J., Wang, K., Chen, Y., Cherubini, A., Valenti, L. V. C., Zheng, S., & Liu, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1954491
Li, X., Chen, H., & Fu, W. (2026) · Gut and Liver · doi:10.5009/gnl260010
Inverse design of chemical perturbations for desired cellular state transitions with GEMGenPreprint
Shao, S., Jiang, Q., Ye, X., Guo, Z., Xia, Y., Liu, Z., Xu, J., Jin, P., Ju, F., Xia, H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11151710/v1
周, 晓., Tang, X., Zhao, H., Duan, X., Yuanxiang, G., Yu, H., Shi, X., & Li, Z. (2026) · Abdominal Radiology · doi:10.1007/s00261-026-05856-9
Trained Immunity and Persistent Myeloid Responsiveness in MASH
Fu, L., Guo, R., Zhang, Q., & Zhang, Q. (2026) · Cells · doi:10.3390/cells15212022
Ma, Z., & Cong, M. (2026) · Hepatobiliary Communications · doi:10.1016/j.hbc.2026.100017
Self-citationHou, Y.-R., Diao, L., Xie, S., Zeng, J., Lai, H.-S., Lv, G., Hu, Y.-X., Liang, M.-C., Huang, T., Xiao, Z., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118202
Bouguéon, M., Legagneux, V., Hazard, O., Bomo, J., Siegel, A., Feret, J., & Théret, N. (2024) · doi:10.1371/journal.pcbi.1011858.r004
Kandhi, R., Yeganeh, M., Yoshimura, A., Menendez, A., Ramanathan, S., & Ilangumaran, S. (2023) · doi:10.3389/fimmu.2023.1259246.s002
Scholp, A. J., Jensen, J., Chinnathambi, S., Atluri, K., Mendenhall, A., Fowler, T., Salem, A. K., Martin, J. A., & Sander, E. A. (2022) · doi:10.3389/fbioe.2022.907611.s004
Liu, T., Li, H., Li, Y., Wang, L., Chen, G., Pu, G., Guo, X., Cho, W. C., Harandi, M. F., Zheng, Y., et al. (2022) · doi:10.3389/fcell.2022.798551.s001
Hecho, S. L. (2014) · theses.fr (ABES) · doi:10.70675/71a595f5zaaccz495cz8a34zd794f422a9a7
Papel del receptor nuclear PPARgamma en la inflamación y la esteatosis hepática
Salvador, E. M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Metadata
- Authors
- Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., & Brenner, D. A.
- Affiliations
- Department of Medicine,
- Universitätsklinikum Aachen (DE)
- Department of Cellular and Molecular Medicine,
- School of Pharmacy, University of California, San Diego, CA 92093;
- University of Southern California (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-05-07
- Volume
- 109
- Issue
- 24
- Pages
- 9448-9453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3386114
- OpenAlex
- W2075290880
- Cited by
- 805
- References
- 27
- Citations by year
- 2026: 29 · 2025: 51 · 2024: 61 · 2023: 59 · 2022: 53 · 2021: 62 · 2020: 64 · 2019: 52 · 2018: 53 · 2017: 61 · 2016: 64 · 2015: 73 · 2014: 63 · 2013: 42 · 2012: 13
- FWCI
- 38.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- myofibroblasts, hepatic stellate cells, liver fibrosis, fibrosis regression, apoptosis, anti-apoptotic genes, carbon tetrachloride, alcohol-induced liver injury, fibrogenic gene expression
- MeSH terms
- Animals, Liver Cirrhosis, Phenotype, Tamoxifen, Adoptive Transfer, Collagen Type I, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.